Evidence Development in Cancer Treatment - Real World: PREDiCTrw
Not Applicable
Recruiting
- Conditions
- Cancer
- Interventions
- Behavioral: QOL - quality of lifeDiagnostic Test: Radiographic or laboratory evaluation
- First Posted Date
- 2024-02-05
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 100
- Registration Number
- NCT06242912
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
Diagnostic CT Palliative Radiotherapy: Feasibility Study of Treating Bone Metastases Without a CT Simulation
Not Applicable
Not yet recruiting
- Conditions
- Bone Metastases
- Interventions
- Other: Diagnostic CT
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 10
- Registration Number
- NCT06235034
Preliminary Assessment of [18F]BL40 in PET/CT Scans
Not yet recruiting
- Conditions
- Diffuse Large B-cell LymphomaMultiple MyelomaMantle Cell LymphomaChronic Lymphocytic LeukemiaMarginal Zone LymphomaWaldenström Macroglobulinemia
- Interventions
- Diagnostic Test: 18F-BL40 PET/CTDiagnostic Test: 18F-FDG PET/CTDiagnostic Test: Routine Blood Draw - Phase 1 only
- First Posted Date
- 2024-01-25
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 30
- Registration Number
- NCT06224309
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
Phase 1
Recruiting
- Conditions
- Mantle Cell LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)Non-Hodgkin's LymphomaDiffuse Large B Cell LymphomaB-Cell LeukemiaHigh-grade B-cell LymphomaB-cell Acute Lymphoblastic LeukemiaB-cell Lymphoma
- Interventions
- First Posted Date
- 2024-01-17
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 24
- Registration Number
- NCT06208735
- Locations
- 🇨🇦
Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta, Canada
🇨🇦Alberta Children's Hospital, Calgary, Alberta, Canada
🇨🇦Vancouver General Hospital, Vancouver, British Columbia, Canada
Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
Recruiting
- Conditions
- Localized Prostate Carcinoma
- Interventions
- Radiation: High dose rate prostate brachytherapy
- First Posted Date
- 2024-01-11
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 100
- Registration Number
- NCT06200974
- Locations
- 🇨🇦
British Columbia Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
Not Applicable
Recruiting
- Conditions
- Oligometastatic DiseaseToxicity Due to RadiotherapyOligoprogressionQuality of Life
- Interventions
- Radiation: Multiple fraction SABROther: QoL reporting aloneRadiation: Single fraction SABROther: QoL reporting, symptom screen and healthcare provider intervention
- First Posted Date
- 2023-03-24
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 598
- Registration Number
- NCT05784428
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
🇨🇦BC Cancer - Victoria, Victoria, British Columbia, Canada
A Case Crossover Study of Intermittent Fasting in CLL/SLL
Not Applicable
Completed
- Conditions
- Small Lymphocytic Lymphoma (SLL)Chronic Lymphocytic Leukemia (CLL)
- Interventions
- Behavioral: 16/8 Method (intermittent fast regimen)
- First Posted Date
- 2023-02-01
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 6
- Registration Number
- NCT05708326
- Locations
- 🇨🇦
Eleah Stringer, Victoria, British Columbia, Canada
STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision
Not Applicable
Not yet recruiting
- Conditions
- Vulvar Cancer
- Interventions
- Procedure: Re-excision
- First Posted Date
- 2022-10-13
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 249
- Registration Number
- NCT05576831
- Locations
- 🇨🇦
BC Cancer - Vancouver Centre, Vancouver, British Columbia, Canada
177Lu-HTK03170 in MCRPC with PSMA Positive Disease
Phase 1
Suspended
- Conditions
- Metastatic Castration-resistant Prostate CancerCastrate Resistant Prostate CancerProstate Cancer Metastatic
- Interventions
- First Posted Date
- 2022-10-07
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 50
- Registration Number
- NCT05570994
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer
Not Applicable
Not yet recruiting
- Conditions
- Head and Neck Cancer
- Interventions
- Diagnostic Test: Whole genomic DNA/RNA tumour sequencing
- First Posted Date
- 2022-05-13
- Last Posted Date
- 2022-05-13
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 500
- Registration Number
- NCT05373251
© Copyright 2025. All Rights Reserved by MedPath